cigna glp-1 news (CI) Faces Cuts in Weight Loss Drug Coverage Amid Ri Why Cigna is capping cost

Research in people with diabetes has found that those treated with GLP-1 receptor agonists were almost twice as likely to test positive for SIBO compared with people treated with other diabetes medications

Current therapeutic uses for CJC-1295 and ipamorelin Like sermorelin, another growth hormone secretagogue, CJC-1295 and ipamorelin are non-FDA-approved medications whose therapeutic uses are entirely off-label

The liquid is typically flavored to mask the taste of the active ingredient, making it more palatable for patients, especially children

Diet , 114 (11), 1860

Here's a closer look

Read article 17 May 2026 Compare AI meal analysis and manual food tracking for diabetes management